Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016
Article in Gynecologic Oncology (April 2024)
The most recent citing publications are shown below. View all 69 publications that cite this research output on Dimensions.
Article in Gynecologic Oncology (April 2024)
Book chapter (January 2023)
Article in Frontiers in Immunology (September 2022)